Sfoglia per Autore
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders
2018-01-01 Barbaraci, Carla; Dichiara, Maria; Turnaturi, Rita; Fallica Antonino, N; Arena, Emanuela; Prezzavento, Orazio; Amata, Emanuele; Marrazzo, Agostino
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors.
2018-01-01 Dichiara, M; Modica, Mn; Leonardi, C; Margani, F; Ciaffaglione, V; Fallica, An; Floresta, G; Gentile, D; Cosenza, J; Pittalà, V.
Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents
2019-01-01 Fallica, Antonino N.; Ciaffaglione, Valeria; Leonardi, Carmen; Dichiara, Maria; Barbaraci, Carla; Catalfo, Alfio; Finocchiaro, GUGLIELMO MARTINO; DE GUIDI, Guido; Amata, Emanuele; Marrazzo, Agostino
Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors
2019-01-01 Intagliata, S.; Salerno, L.; Ciaffaglione, V.; Leonardi, C.; Fallica, A. N.; Carota, G.; Amata, E.; Marrazzo, A.; Pittala, V.; Romeo, G.
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region
2020-01-01 Floresta, Giuseppe; Fallica, Antonino N.; Romeo, Giuseppe; Sorrenti, Valeria; Salerno, Loredana; Rescifina, Antonio; Pittalà, Valeria
The potential role of sildenafil in cancer management through epr augmentation
2021-01-01 Haider, M.; Elsherbeny, A.; Pittala, V.; Fallica, A. N.; Alghamdi, M. A.; Greish, K.
Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation
2021-01-01 Salerno, L.; Vanella, L.; Sorrenti, V.; Consoli, V.; Ciaffaglione, V.; Fallica, A. N.; Canale, V.; Zajdel, P.; Pignatello, R.; Intagliata, S.
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity
2021-01-01 Fallica, A. N.; Sorrenti, V.; D'Amico, A. G.; Salerno, L.; Romeo, G.; Intagliata, S.; Consoli, V.; Floresta, G.; Rescifina, A.; D'Agata, V.; Vanella, L.; Pittala, V.
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes
2021-01-01 Floresta, G.; Fallica, A. N.; Salerno, L.; Sorrenti, V.; Pittala, V.; Rescifina, A.
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents
2021-01-01 Fallica, A. N.; Barbaraci, C.; Amata, E.; Pasquinucci, L.; Turnaturi, R.; Dichiara, M.; Intagliata, S.; Gariboldi, M. B.; Marras, E.; Orlandi, V. T.; Ferroni, C.; Martini, C.; Rescifina, A.; Gentile, D.; Varchi, G.; Marrazzo, A.
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes
2021-01-01 Floresta, G.; Fallica, A. N.; Patamia, V.; Sorrenti, V.; Greish, K.; Rescifina, A.; Pittala, V.
Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective
2021-01-01 Fallica, Antonino N; Pittalà, Valeria; Modica, Maria N; Salerno, Loredana; Romeo, Giuseppe; Marrazzo, Agostino; Helal, Mohamed A; Intagliata, Sebastiano
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders | 1-gen-2018 | Barbaraci, Carla; Dichiara, Maria; Turnaturi, Rita; Fallica Antonino, N; Arena, Emanuela; Prezzavento, Orazio; Amata, Emanuele; Marrazzo, Agostino | |
| Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. | 1-gen-2018 | Dichiara, M; Modica, Mn; Leonardi, C; Margani, F; Ciaffaglione, V; Fallica, An; Floresta, G; Gentile, D; Cosenza, J; Pittalà, V. | |
| Synthesis of “no-light activated” Ciprofloxacin and Norfloxacin derivatives as potential biofilm dispersant agents | 1-gen-2019 | Fallica, Antonino N.; Ciaffaglione, Valeria; Leonardi, Carmen; Dichiara, Maria; Barbaraci, Carla; Catalfo, Alfio; Finocchiaro, GUGLIELMO MARTINO; DE GUIDI, Guido; Amata, Emanuele; Marrazzo, Agostino | |
| Heme Oxygenase-2 (HO-2) as a therapeutic target: Activators and inhibitors | 1-gen-2019 | Intagliata, S.; Salerno, L.; Ciaffaglione, V.; Leonardi, C.; Fallica, A. N.; Carota, G.; Amata, E.; Marrazzo, A.; Pittala, V.; Romeo, G. | |
| Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region | 1-gen-2020 | Floresta, Giuseppe; Fallica, Antonino N.; Romeo, Giuseppe; Sorrenti, Valeria; Salerno, Loredana; Rescifina, Antonio; Pittalà, Valeria | |
| The potential role of sildenafil in cancer management through epr augmentation | 1-gen-2021 | Haider, M.; Elsherbeny, A.; Pittala, V.; Fallica, A. N.; Alghamdi, M. A.; Greish, K. | |
| Novel mutual prodrug of 5-fluorouracil and heme oxygenase-1 inhibitor (5-FU/HO-1 hybrid): design and preliminary in vitro evaluation | 1-gen-2021 | Salerno, L.; Vanella, L.; Sorrenti, V.; Consoli, V.; Ciaffaglione, V.; Fallica, A. N.; Canale, V.; Zajdel, P.; Pignatello, R.; Intagliata, S. | |
| Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity | 1-gen-2021 | Fallica, A. N.; Sorrenti, V.; D'Amico, A. G.; Salerno, L.; Romeo, G.; Intagliata, S.; Consoli, V.; Floresta, G.; Rescifina, A.; D'Agata, V.; Vanella, L.; Pittala, V. | |
| Growing the molecular architecture of imidazole-like ligands in HO-1 complexes | 1-gen-2021 | Floresta, G.; Fallica, A. N.; Salerno, L.; Sorrenti, V.; Pittala, V.; Rescifina, A. | |
| Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents | 1-gen-2021 | Fallica, A. N.; Barbaraci, C.; Amata, E.; Pasquinucci, L.; Turnaturi, R.; Dichiara, M.; Intagliata, S.; Gariboldi, M. B.; Marras, E.; Orlandi, V. T.; Ferroni, C.; Martini, C.; Rescifina, A.; Gentile, D.; Varchi, G.; Marrazzo, A. | |
| From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes | 1-gen-2021 | Floresta, G.; Fallica, A. N.; Patamia, V.; Sorrenti, V.; Greish, K.; Rescifina, A.; Pittala, V. | |
| Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective | 1-gen-2021 | Fallica, Antonino N; Pittalà, Valeria; Modica, Maria N; Salerno, Loredana; Romeo, Giuseppe; Marrazzo, Agostino; Helal, Mohamed A; Intagliata, Sebastiano |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile